Study demonstrates benefits of Mediterranean diet, gut microbiome and non-alcoholic fatty liver disease in Spain. In the study led by the IBIMA BIONAND Platform group Obesity, Diabetes and Their Comorbidities: Prevention and Treatment and a member of the Pathophysiology of Obesity and Nutrition in the CIBER Region (CIBEROBN), several teams from the PREDIMED-Plus study on diet worked at the Mediterránea and Biomedical Research Center of the CIBER Network. At work, A
Predimide-Plus Alternative 297 participants from the Malaga and Reus nodes were assessed and grouped into three groups based on how biochemical markers associated with NAFLD changed during a year of Mediterranean diet intervention. The results revealed significant changes in the gut microbiome of participants who
I experienced more pronounced improvements in markers of non-alcoholic fatty liver disease. Specifically, participants with a lower suspicion of liver injury showed a higher abundance of some beneficial bacteria, compared to those with a higher degree of liver damage.
More benefits of the Mediterranean diet
Moreover, there are other types of Changes in intestinal microbiota associated with changes in biochemical markers. For example, participants who experienced significant improvement in biochemical indicators related to liver metabolic health and better response to the Mediterranean diet showed a decrease in bacteria associated with inflammatory processes and an increase in bacteria involved in fatty acid production. Which has multiple benefits, including maintaining intestinal health and reducing the risk of disease. These kinds of discoveries once again highlight the benefits of the Mediterranean diet. In this case, it will help us prevent non-alcoholic fatty liver and a wide range of diseases and health problems associated with it.
